Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Joint Bone Spine Année : 2009

Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature

Michel de Bandt
  • Fonction : Auteur
Elisabeth Solau-Gervais
  • Fonction : Auteur
  • PersonId : 1290682
  • IdRef : 073402273
Vincent Goeb
Isabelle Azais
  • Fonction : Auteur
Antoine Martin
  • Fonction : Auteur
Beatrice Pallot-Prades
  • Fonction : Auteur
Yves Maugars
  • Fonction : Auteur
  • PersonId : 906859
Xavier Mariette

Résumé

Objective: To report on the outcome of 15 cases of pregnancies in women treated with anti-TNF drugs during conception or pregnancy Methods: French rheumatologists connecting to the web-site of CRI site: http://www.cri-net.com were asked to fill in a structured questionnaire reporting the outcome of pregnancy in women still treated by a TNF blocker at the time of conception. Results: Spondylarthropathies (n = 8), rheumatoid arthritis (n = 4), juvenile idiopathic arthritis (it = 2), and psoriatic arthritis (n = 1) were treated by infliximab (n = 3), adalimumab (n = 2), or etanercept (n = 10). Miscarriages occurred twice, and elective termination was preferred once. Anti-TNF had been administered during the first, second and third trimester of pregnancy in 12, three and two cases. The 12 babies were in good condition, without apparent malformation or symptoms of neonatal illnesses. Conclusion: The number of reported cases exceeds 300, but only 29 women were treated during their whole pregnancy. The rate of congenital malformations observed so far might appear reassuring compared to the general population for women exposed only during conception. Conversely, there are too few reports of exposure during pregnancy to allow any conclusion about the safety of TNF blockers, and additional long term follow-up of children would be welcome in order to rule out minor forms of VACTERL association that might have been overlooked at birth. (C) 2008 Elsevier Masson SAS. All rights reserved.
Fichier non déposé

Dates et versions

hal-00618741 , version 1 (02-09-2011)

Identifiants

  • HAL Id : hal-00618741 , version 1

Citer

Jean-Marie Berthelot, Michel de Bandt, Philippe Goupille, Elisabeth Solau-Gervais, Frederic Liote, et al.. Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature. Joint Bone Spine, 2009, 76 (1), pp.28-34. ⟨hal-00618741⟩
108 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More